Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIthaca Energy Regulatory News (ITH)

Share Price Information for Ithaca Energy (ITH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.20
Bid: 122.20
Ask: 122.80
Change: 0.40 (0.33%)
Spread: 0.60 (0.491%)
Open: 121.80
High: 123.60
Low: 121.00
Prev. Close: 121.80
ITH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- ITIS Holdings PLC - Replacement

13 Jan 2009 11:34

RNS Number : 5433L
Rathbone Brothers PLC
13 January 2009
 

  FORM 8.3

AMENDMENT - CONSOLIDATED FOR RATHBONE INVESTMENT MANAGEMENT LIMITED AND RATHBONE UNIT TRUST MANAGEMENT LIMITED

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the City Code on Takeovers and Mergers)

1. KEY INFORMATION

Name of person dealing  (Note 1)

Rathbone Brothers Plc (Entity reporting)

Company dealt in

ITIS Holdings Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

2p Ordinary

Date of dealing

12th January 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

686,343  (0.68)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

686,343 (0.68)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

n/a

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

n/a

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

SALE

1,205,500

6.45p

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

n/a

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

n/a

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

n/a

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

n/a

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

13th January 2009

Contact name

Chris Whitehead

Telephone number

020 7399 0000

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGUUMPGUPBGGW
Date   Source Headline
7th Jun 20247:00 amRNSDirector/PDMR Shareholding
6th Jun 20242:59 pmRNSDirector/PDMR Shareholding
29th May 20248:14 amRNSNotice of AGM
28th May 20247:01 amRNSFirst Quarter Results
28th May 20247:00 amRNSBoard of Directors & Executive Management Changes
16th May 20244:11 pmRNSSenior Independent Director Appointment
9th May 20249:33 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSCredit Rating Upgrade Reviews
1st May 20244:20 pmRNSDirector/PDMR Shareholding
23rd Apr 20245:33 pmRNSTransformational combination with ENI UK
17th Apr 20247:00 amRNSPDMR and PCA Notification
10th Apr 20249:59 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSThird Interim Dividend
2nd Apr 20247:00 amRNSDirectorate Change
27th Mar 20247:00 amRNSFull Year 2023 Results
27th Mar 20247:00 amRNSExclusivity Agreement with Eni S.p.A's UK Business
21st Mar 20247:00 amRNSAnnouncement of Interim Dividend
6th Mar 20242:17 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSFY 2023 Trading Update
7th Feb 202410:16 amRNSDirector/PDMR Shareholding
11th Jan 20242:11 pmRNSDirectors'/PDMR Shareholdings
5th Jan 20247:00 amRNSChief Executive Officer Change
7th Dec 20239:40 amRNSDirector/PDMR Shareholding
4th Dec 20232:22 pmRNSDirector/PDMR Shareholding
30th Nov 202310:37 amRNSSuccessful Completion of Remaining Stake in Cambo
23rd Nov 20231:49 pmRNSChange of Registered Office
22nd Nov 20237:00 amRNSQ3 2023 Financial Results
10th Nov 20231:22 pmRNSDirectors’/PDMR Shareholdings
1st Nov 20239:00 amRNSCompletion of acquisition remaining stake in Fotla
19th Oct 202312:14 pmRNSAdmission of Shares
10th Oct 202310:26 amRNSDirectors’/PDMR Shareholdings
4th Oct 202312:01 pmRNSIssue of Shares to the Employee Benefit Trust
3rd Oct 20234:40 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSIthaca Energy Development of the Rosebank Field
12th Sep 20237:00 amRNSIthaca to acquire remaining interest in Cambo
8th Sep 20239:59 amRNSDirectors’/PDMR Shareholdings
8th Sep 20237:00 amRNSSecond interim dividend for 2023
23rd Aug 20237:00 amRNSFirst Half Results for Six Months to 30 June 2023
23rd Aug 20237:00 amRNSAnnouncement of Interim Dividend
8th Aug 20234:57 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNSK2 Successful Exploration Well Results
12th Jul 20237:00 amRNSAcquisition of Fotla & three exploration licenses
7th Jul 20233:27 pmRNSDirectors’/PDMR Shareholdings
7th Jul 20233:00 pmRNSNon-Executive Director - Directorship update
21st Jun 20235:54 pmRNSDirector Dealings and Shareholdings
20th Jun 202310:15 amRNSChange of Registered Office
7th Jun 20238:10 amRNSDirectors’/PDMR Shareholdings
31st May 20237:00 amRNSFirst Quarter Results
26th May 20239:01 amRNSAmended PDMR and PCA Notification
24th May 20234:51 pmRNSResults of Annual General Meeting 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.